Home
ALZN
ALZN News

Latest Alzamend Neuro Inc. (ALZN) News on November 19, 2025

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

PR Newswire

8 hours ago

Alzamend Neuro Announces Completion of Clinical Portion of Phase II Clinical Trial of AL001 "Lithium in Brain" Study Conducted at Massachusetts General Hospital

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants

Benzinga

8 hours ago

EXCLUSIVE: Alzamend Wraps Clinical Phase Of AL001 Study In Healthy Participants

MT Newswires

a month ago

Alzamend Neuro Insider Sold Shares Worth $344,222, According to a Recent SEC Filing

Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

GlobeNewswire

5 months ago

Alzamend Neuro Announces Final Closing of $5 Million Private Placement Months Ahead of Schedule

MT Newswires

6 months ago

Sector Update: Health Care

MT Newswires

6 months ago

Top Midday Gainers

MT Newswires

6 months ago

Alzamend Neuro Doses First Patient in Phase 2 Study of AL001 Lithium Therapy

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

GlobeNewswire

6 months ago

Alzamend Neuro Announces Dosing of First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

GlobeNewswire

6 months ago

Alzamend Neuro Enrolls First Patient in its Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

GlobeNewswire

6 months ago

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants

Benzinga

6 months ago

EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants

Alzamend Neuro Announces Reverse Stock Split

GlobeNewswire

6 months ago

Alzamend Neuro Announces Reverse Stock Split

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

GlobeNewswire

6 months ago

Alzamend Neuro Partners with QMENTA, to Advance AI-Powered Imaging for its Phase II Clinical Trial of AL001 Study to Take Place at Massachusetts General Hospital

EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program

Benzinga

6 months ago

EXCLUSIVE: Alzamend Neuro Partners with QMENTA To Advance AI-Powered Imaging For Is Phase 2 Trial Of Lead Program

Alzamend Neuro (ALZN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Zacks

7 months ago

Alzamend Neuro (ALZN) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?

Insider Monkey

8 months ago

Is Alzamend Neuro, Inc. (ALZN) the Cheapest Stock Insiders Are Buying In March?

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

GlobeNewswire

8 months ago

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

GlobeNewswire

8 months ago

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Major Depressive Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

GlobeNewswire

8 months ago

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Post-Traumatic Stress Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

GlobeNewswire

9 months ago

Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Bipolar Disorder to take Place at Massachusetts General Hospital

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

GlobeNewswire

9 months ago

Alzamend Neuro Announces Initiation Date of First Phase II Clinical Trial of AL001 to take Place at Massachusetts General Hospital

EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025

Benzinga

9 months ago

EXCLUSIVE: Alzamend Neuro To Start First Phase 2 Study For Lead Candidate In 2025

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

Business Wire

9 months ago

Alzamend Neuro Announces Completion of a Novel Head Coil by Tesla for Measuring Brain Structure Lithium Levels in Five Upcoming Phase II Clinical Trials at Massachusetts General Hospital

EXCLUSIVE: Alzamend Neuro Says Tesla Dynamic Completes Head Coil To Measure Brain Structure Lithium Levels

Benzinga

9 months ago

EXCLUSIVE: Alzamend Neuro Says Tesla Dynamic Completes Head Coil To Measure Brain Structure Lithium Levels

Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?

Zacks

10 months ago

Has Alzamend Neuro (ALZN) Outpaced Other Medical Stocks This Year?

Alzamend Neuro to Present at the Sequire Investor Summit

Business Wire

10 months ago

Alzamend Neuro to Present at the Sequire Investor Summit

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Business Wire

a year ago

Alzamend Neuro to Present Non-Clinical Data Update at the Society of Toxicology 2025 Annual Meeting and ToxExpo

Alzamend Neuro says net cash gained by financing activity $8.3M

TipRanks

a year ago

Alzamend Neuro says net cash gained by financing activity $8.3M

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

Business Wire

a year ago

Alzamend Neuro Reports Second Quarter 2025 Financial Results and Provides Update on Clinical Programs

Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer’s Transgenic Mice

Business Wire

a year ago

Alzamend Neuro Announces Full Data Set from its Nonclinical Study: Comparing Brain and Plasma Lithium Exposures between AL001 and Lithium Carbonate in Alzheimer’s Transgenic Mice

EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential

Benzinga

a year ago

EXCLUSIVE: Alzamend Neuro Reveals Full Data From Nonclinical Study Of Its Lead Alzheimer's Drug Potential

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Business Wire

a year ago

Alzamend Neuro Announces Full Data Set from Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's

Benzinga

a year ago

EXCLUSIVE: Alzamend Neuro Reveals Full Data Set From Multiple Ascending Dose Trial For Lead Candidate For Dementia Related to Alzheimer's

MT Newswires

a year ago

Alzamend Neuro Regains Nasdaq Compliance Over Listing Requirements

Alzamend Neuro Regains Compliance with Nasdaq Listing Standards

Business Wire

a year ago

Alzamend Neuro Regains Compliance with Nasdaq Listing Standards

Alzamend Neuro CEO Stephan Jackman to Participate in the Maxim Group’s Virtual Healthcare Conference

Business Wire

a year ago

Alzamend Neuro CEO Stephan Jackman to Participate in the Maxim Group’s Virtual Healthcare Conference

Alzamend Neuro Issues Letter to Stockholders

Business Wire

a year ago

Alzamend Neuro Issues Letter to Stockholders

MT Newswires

a year ago

Top Midday Gainers

MT Newswires

a year ago

Alzamend Neuro Enters Partnership for Phase II Clinical Trial of Potential Lithium Therapeutic Drug for Post-Traumatic Stress Disorder; Shares Soar

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder

Business Wire

a year ago

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder

Business Wire

a year ago

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder

Business Wire

a year ago

Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder

Alzamend Neuro partners with Mass General for Alzheimer’s treatment trial

Clinical Trials Arena

a year ago

Alzamend Neuro partners with Mass General for Alzheimer’s treatment trial

EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study

Benzinga

a year ago

EXCLUSIVE: Alzamend Neuro To Assess AL001 Alzheimer's Candidate Against Commonly Marketed Lithium Salt In Phase 2 Head-To-Head Study

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Business Wire

a year ago

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

MT Newswires

a year ago

Alzamend Neuro Board Approves 1-for-10 Reverse Stock Split

Alzamend Neuro Announces Reverse Stock Split

Business Wire

a year ago

Alzamend Neuro Announces Reverse Stock Split

Journal-News, Hamilton, Ohio

a year ago

Retiring ODW executive to be first inductee in Hamilton Business Hall of Fame

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

TechCrunch

a year ago

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Motley Fool

a year ago

Once-in-a-Generation Investment Opportunity: Why You Should Buy Carnival Stock Now

Italian energy company targets Britain for fleet of 20 mini-nukes

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy StepStone Group LP (NASDAQ:STEP) For Its Next Dividend

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Bloomberg

a year ago

Saudis Said to Hand About 60% of Aramco Offer to Foreigners

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Simply Wall St.

a year ago

Is Now The Time To Put Planet Fitness (NYSE:PLNT) On Your Watchlist?

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Simply Wall St.

a year ago

Don't Buy Banc of California, Inc. (NYSE:BANC) For Its Next Dividend Without Doing These Checks

Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel

Business Wire

a year ago

Alzamend Neuro Announces Favorable Decision from Nasdaq Hearings Panel

Alzamend Neuro Announces Initial Closing of Private Placement

Business Wire

2 years ago

Alzamend Neuro Announces Initial Closing of Private Placement

EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares

Benzinga

2 years ago

EXCLUSIVE: Alzamend Neuro To Raise Up To $25M Via Private Placement Of Preferred Shares

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

Business Wire

2 years ago

Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program

Business Wire

2 years ago

Alzamend Neuro Announces Termination of At-the-Market Equity Offering Program

Insiders Are Buying These 11 Penny Stocks

Insider Monkey

2 years ago

Insiders Are Buying These 11 Penny Stocks

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

GlobeNewswire

2 years ago

New to The Street TV Announces Episode #552 with its Five Business Guest Interviews, Airs on Bloomberg TV as Sponsored Programming, Tonight, February 1, 2024, at 9:30 PM PT

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application

GlobeNewswire

2 years ago

Theratechnologies Receives Update from FDA on Tesamorelin F8 Supplemental Biologic License Application

POET Technologies Upsizes Non-Brokered Private Placement

GlobeNewswire

2 years ago

POET Technologies Upsizes Non-Brokered Private Placement

The 3 Best Hydrogen Stocks to Buy in January 2024

InvestorPlace

2 years ago

The 3 Best Hydrogen Stocks to Buy in January 2024

Solar360, Repsol and Telefónica Joint Venture, Partners with Turbo Energy to Revolutionize Solar Self-Consumption Through Artificial Intelligence

GlobeNewswire

2 years ago

Solar360, Repsol and Telefónica Joint Venture, Partners with Turbo Energy to Revolutionize Solar Self-Consumption Through Artificial Intelligence

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

GlobeNewswire

2 years ago

FAT Brands Makes West Coast Debut of Co-Branded Johnny Rockets and Hurricane Wings

Bitcoin Depot to Present at the Sidoti Micro-Cap Virtual Investor Conference

GlobeNewswire

2 years ago

Bitcoin Depot to Present at the Sidoti Micro-Cap Virtual Investor Conference

Are Investors Undervaluing First United (FUNC) Right Now?

Zacks

2 years ago

Are Investors Undervaluing First United (FUNC) Right Now?

Tuttle Capital Management Launches 2x Inverse Regional Bank ETF

GlobeNewswire

2 years ago

Tuttle Capital Management Launches 2x Inverse Regional Bank ETF

GlobeNewswire

2 years ago

Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination

WANG & LEE GROUP First Half 2023 Earnings: US$0.11 loss per share (vs US$0.032 loss in 1H 2022)

Simply Wall St.

2 years ago

WANG & LEE GROUP First Half 2023 Earnings: US$0.11 loss per share (vs US$0.032 loss in 1H 2022)

Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering

PR Newswire

2 years ago

Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering

Banzai CEO Purchases Additional Shares in Market

GlobeNewswire

2 years ago

Banzai CEO Purchases Additional Shares in Market

Hudson Acquisition I Corp. Receives Notification from Nasdaq Regarding Minimum Market Value Deficiency

GlobeNewswire

2 years ago

Hudson Acquisition I Corp. Receives Notification from Nasdaq Regarding Minimum Market Value Deficiency

Reuters

2 years ago

Israeli food importer G. Willi warns of delays, higher costs from Red Sea attacks

G. Willi-Food international reports the results of THIRD quarter 2023

PR Newswire

2 years ago

G. Willi-Food international reports the results of THIRD quarter 2023

Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024

Business Wire

2 years ago

Botensilimab/Balstilimab Data in Neoadjuvant Colorectal Cancer Selected for ASCO-GI 2024

Notable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial Outcome

GlobeNewswire

2 years ago

Notable Reports Predictive Precision Medicine Platform (PPMP) Accurately Predicted Fosciclopirox Trial Outcome

Barnwell Industries, Inc. Reports Fourth Quarter and Year End Results

GlobeNewswire

2 years ago

Barnwell Industries, Inc. Reports Fourth Quarter and Year End Results

Blackboxstocks, Inc. Signs Definitive Agreement to Acquire Evtec Aluminium, Supplier of Proprietary Parts for the EV, Hybrid, and Performance Automotive Market, with Projected Revenue of US$52 Million for Fiscal Year Ending June 30, 2024

Business Wire

2 years ago

Blackboxstocks, Inc. Signs Definitive Agreement to Acquire Evtec Aluminium, Supplier of Proprietary Parts for the EV, Hybrid, and Performance Automotive Market, with Projected Revenue of US$52 Million for Fiscal Year Ending June 30, 2024

PR Newswire

2 years ago

Moatable Announces Receipt of NYSE Non-compliance Letter Regarding ADS Trading Price

EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year

Benzinga

2 years ago

EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year

Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients

Business Wire

2 years ago

Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients

Business Wire

2 years ago

The Beachbody Company, Inc. Announces $5,300,000 Registered Direct Offering

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

PR Newswire

2 years ago

Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine

BODi Helps End After-Dinner Suffering This Thanksgiving

Business Wire

2 years ago

BODi Helps End After-Dinner Suffering This Thanksgiving

Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients

Business Wire

2 years ago

Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Major Depressive Disorder Patients

Moatable Reports Third Quarter 2023 Financial Results

PR Newswire

2 years ago

Moatable Reports Third Quarter 2023 Financial Results

BurgerFi International, Inc. (NASDAQ:BFI) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

BurgerFi International, Inc. (NASDAQ:BFI) Q3 2023 Earnings Call Transcript

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Business Wire

2 years ago

Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

Business Wire

2 years ago

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

Sonder Holdings Inc. Announces Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Sonder Holdings Inc. Announces Third Quarter 2023 Financial Results

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

ACCESSWIRE

2 years ago

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

Twin Vee Powercats Co. (NASDAQ:VEEE) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Twin Vee Powercats Co. (NASDAQ:VEEE) Q3 2023 Earnings Call Transcript

PLAYSTUDIOS Secures Exclusive Five-Year Extension to Iconic TETRIS® Mobile License

Business Wire

2 years ago

PLAYSTUDIOS Secures Exclusive Five-Year Extension to Iconic TETRIS® Mobile License

Li-Cycle Reports Third Quarter 2023 Financial Results and Provides Business Update

Business Wire

2 years ago

Li-Cycle Reports Third Quarter 2023 Financial Results and Provides Business Update

Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001

Business Wire

2 years ago

Alzamend Neuro Submits IND Application for a Phase IIA Clinical Trial in Post-Traumatic Stress Disorder Patients of Next‑Generation Lithium Therapeutic Drug Candidate AL001

Virgin Galactic, Astra Space: Space flight stocks soar high

Yahoo Finance Video

2 years ago

Virgin Galactic, Astra Space: Space flight stocks soar high

The Eastern Company (NASDAQ:EML) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Simply Wall St.

2 years ago

The Eastern Company (NASDAQ:EML) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

Share on Social Networks: